Clinical Trials Logo

HIV Risk clinical trials

View clinical trials related to HIV Risk.

Filter by:

NCT ID: NCT05828849 Not yet recruiting - Clinical trials for Cardiovascular Disease

Mortality Reductions Based on AUD/Heavy Alcohol Use, HIV Risk, and Cardiovascular Risk

Start date: April 15, 2024
Phase: N/A
Study type: Interventional

The purpose of this research study is to investigate if a personalized intervention including parts such as navigation (focus on patient outreach efforts, missed and completed encounters), personalization (individual health benefits) and compensation (value health-related costs borne by patients) will help people reduce their chances of dying from preventable causes, including heart attacks, strokes, drinking alcohol, substance abuse, HIV, and other conditions.

NCT ID: NCT05368571 Recruiting - HIV Risk Clinical Trials

CHOICES-TEEN Randomized Controlled Trial

Start date: April 8, 2022
Phase: N/A
Study type: Interventional

This randomized controlled trial will: 1) Test the efficacy of the CHOICES-TEEN (CT) intervention compared with an Attentional Control (AC) condition on reducing the risk of substance-exposed pregnancy (SEP) and HIV/STI among high-risk female youth involved with the juvenile justice system by reducing alcohol use, increasing marijuana cessation, reducing risk of pregnancy, and increasing condom use; 2) Test the efficacy of CT, compared to AC, on increasing cognitive self-regulation abilities; 3) Test proposed intervention mediators/mechanisms of action for CT overall and by race/ethnicity; and 4) Test the moderating effect of initial readiness to change on risk of SEP and risk of HIV/STI.

NCT ID: NCT04718194 Completed - Sexual Behavior Clinical Trials

Developing Online Interventions to Reduce Stigma-Related Stress, Sexual Health, and HIV Risk Among Young Chinese MSM

Start date: April 19, 2021
Phase: N/A
Study type: Interventional

This study is a 2-arm RCT that will assess the efficacy of a culturally adapted, 10-session SGM-affirmative, internet-based cognitive behavioral therapy (iCBT) among young men who have sex with men (YMSM) in Hunan province China. The affirmative treatment called ESTEEM is based on a minority stress-focused, CBT framework. In collaboration with colleagues at Central South University (CSU), the investigators will assess whether a culturally adapted version of iCBT ESTEEM demonstrates significant reductions in HIV risk behavior and mental health symptoms (e.g., depression, anxiety) compared to self-monitoring of stress and mood.

NCT ID: NCT03664362 Completed - Stress Clinical Trials

The BSHAPE Intervention Program for Safety and Health of Survivors of Cumulative Trauma

BSHAPE
Start date: October 10, 2018
Phase: N/A
Study type: Interventional

The goal of the BSHAPE study is to test a trauma informed, culturally tailored, multicomponent program entitled BSHAPE (Being Safe, Healthy, And Positively Empowered) for immigrant survivors of cumulative trauma.

NCT ID: NCT02998320 Completed - HIV Risk Clinical Trials

Evaluation of Compliance With Treatment by Genvoya in HIV Post-exposure Prophylaxis

Start date: March 10, 2017
Phase: Phase 3
Study type: Interventional

This study measures the proportion of enrolled patients taking the uninterrupted HIV post-exposure prophylaxis Genvoya for four weeks

NCT ID: NCT02611362 Completed - PrEP Clinical Trials

A Multilevel Gaming Intervention for Persons on PrEP

Start date: April 2015
Phase: N/A
Study type: Interventional

This study will develop and test a novel, smartphone based gaming intervention to improve adherence to medication to prevent HIV (known as Pre-exposure Prophylaxis, PrEP) and to decrease HIV risk behaviors among men who have sex with men (MSM). In the intervention, participants will engage with an immersive app/game on their iPhone. While gaming, participants will gain information about their health, improve motivation for PrEP and medical appointment adherence, and practice healthy behaviors. If the intervention is found to be effective, it can be tested in a larger study and then disseminated to other people taking PrEP.

NCT ID: NCT02112201 Completed - Substance Use Clinical Trials

The ProGirls Study

Start date: September 2013
Phase: N/A
Study type: Interventional

Girls in the juvenile justice system who have high rates of delinquency, drug abuse, and trauma are particularly at risk for engaging in risky sexual behavior and for contracting HIV/AIDS or other sexually transmitted infections (STIs). No effective prevention programs for girls who have this combination of behaviors is known to exist at this time. Researchers are developing, assessing, and implementing a family-centered prevention program to decrease girls' participation in the risky behaviors associated with the spread of HIV and STIs. The program also includes a group-based training and support program for parents.

NCT ID: NCT01866046 Completed - HIV Risk Clinical Trials

Rapid HIV Testing and Counseling in High Risk Women in Shelters

Start date: January 2013
Phase: Phase 1
Study type: Interventional

This is a developmental study evaluating a new rapid HIV testing and risk prevention intervention for residents of battered women's shelters who endorse risky sexual behaviors.

NCT ID: NCT01381146 Withdrawn - Substance Abuse Clinical Trials

Victim Impact Modules for Jail Inmates

Start date: July 15, 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate feasibility of modularized delivery of the Impact of Crime (IOC) group intervention with jail inmates, and obtain preliminary data on its effectiveness in reducing post-release recidivism, substance abuse, and HIV risk behavior.

NCT ID: NCT01380977 Active, not recruiting - Substance Abuse Clinical Trials

Trial of Impact of Crime Group Intervention for Jail Inmates

IOC-1
Start date: August 2002
Phase: Phase 1/Phase 2
Study type: Interventional

This pilot study is designed to evaluate the efficacy of the Impact of Crime (IOC) group intervention for jail inmates. The hypothesis is that participants in IOC will show decreases in criminogenic thinking, decreases in shame, increases in guilt, and increases in empathy, which in turn will be reflected in reduced recidivism (official records and self report), relative to those randomly assigned to a treatment as usual group.